DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Viyash Scientific Limited — Acquisition

NSE 1 hr ago·2 Nov 2026, 12:05 pm

Viyash Scientific

Viyash Scientific Limited has announced the incorporation of a wholly-owned subsidiary in Vietnam. This new entity will serve as a step-down subsidiary, allowing the company to manage its international operations more effectively from the ground up.

For investors, this move signals Viyash's strategic intent to expand its footprint in the Asian market. It demonstrates the company's focus on scaling its manufacturing and supply chain capabilities beyond its domestic base, which could support future revenue growth.

Investors should watch for updates on the subsidiary's specific business activities and capital allocation. The progress of this new venture will be key to understanding how it contributes to Viyash's long-term growth strategy.